Back to Agenda
Session 5: HTA 2.0: a Glimpse into Current uses and Future Trends
Session Chair(s)
Mourad Aboubakr
MENA Regional Head Market Access, Novartis, United Arab Emirates
Noha Salem
Regional Director for Healthcare Policy, EEMEA, MSD, Egypt
Recently, HTA has become one of the most important topics across the region as governments aspire to modernize healthcare systems and adopt contemporary measures for evaluating healthcare interventions. This session will shed light on the past, present and future of HTA through the participation of industry, international bodies, government and academic experts, and the discussion of topics such as lessons from the past, the current state of play and recommendations for moving towards a value-based system and integrating HTA into the broader healthcare context.
Speaker(s)
Ansgar Hebborn, PHD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
EUnetHTA – Where and Why it Started & Lessons Learned - Remote Presentation
Anna-Eva Ampelas, LLM
Head of Unit, Unit B6 Medical Devices and Health Technology Assessment, DG SANTE, European Commission, Belgium
How to get to an international approach in HTA – Video contribution
Ibrahim A. Al Juffali
Advisor to the Minister of Health for Pharmaceutical Sector Development, Assistant Professor, Department of Pharmaceutics, College of Pharmacy, King Saud, Saudi Arabia
Health Technology Assessment in Saudi Arabia: Experts Perception on the Creation of a National HTA Entity
Mourad Aboubakr
MENA Regional Head Market Access, Novartis, United Arab Emirates
Health Technology Assessment: the Innovation Industry Perspective
Panos Kanavos
Deputy Director, LSE Health, London School of Economics, United Kingdom
HTA in the Middle East region – A mapping of the current landscape and options for the future
Shaimaa Foad
Pharmacoeconomic Unit, Central Administration of Pharmaceutical Affairs (CAPA) Egypt, Egypt
Q&A and Panel discussion on Implementing the right HTA system: pitfalls, best-practices and recommendations, with the participation of:
Have an account?
